We are excited to share that Minutia's co-founder and CEO,?Catherine "Katy" Digovich, has been selected to join?this year’s cohort of Termeer Fellows! This is a fantastic opportunity for Katy to grow as a leader in our field, learning from The Termeer Foundation?Mentors and Advisors, as well as peers in the Fellowship Program.?Katy's progress will, in turn,?strengthen Minutia as a biotech company creating a novel cell therapy-based cure for insulin-dependent diabetes.? Go team!! #TermeerFellows #HealthcareInnovation #LeadershipJourney #Mentorship #FutureOfHealthcare #T1D #type1diabetes #curediabetes #celltherapy #biotech
Welcoming the 2025 Termeer Fellows! We are honored to introduce the Class of 2025 Termeer Fellows—a distinguished group of 17 visionary leaders, our largest class to date, who are shaping the future of healthcare innovation. These first-time CEOs and founders are driving breakthrough discoveries and tackling some of the most complex challenges in biotech and life sciences, all with a steadfast commitment to transforming patient care. Through the Termeer Fellowship, these innovators will gain access to values-driven leadership content, expert mentorship, access to executive coaches, and a global network of industry leaders, all dedicated to accelerating their impact on patients worldwide. Now in its eighth year, the Fellowship remains committed to empowering the next generation of biotech pioneers with the support, community, and resources they need to thrive. Join us in congratulating the 2025 Termeer Fellows! Learn more about their groundbreaking work and the impact they are making in healthcare. Read more at https://lnkd.in/eCPFSXpD. 2025 Termeer Fellows: Rachel Abbott, CEO, Pan Cancer T Catherine "Katy" Digovich, CEO and Co-Founder, Minutia Aisling Foley, CEO and Co-Founder, ExCulture Sophia Lugo, CEO and Chairman, Radar Therapeutics Robert Kruse, CEO and Co-Founder, HydroGene Therapeutics Luca Giani, CEO and Co-Founder, Ilios Therapeutics Lauren Gehman, CEO and Co-Founder, Merge Therapeutics Antonio Henriques, CEO and Co-Founder, Momentum Therapeutics Alex Hersham, Co-Founder, Nonsense Tx Noor Jailkhani, CEO and Co-Founder, Matrisome Bio Demetri Maxim, CEO and Founder, Nephrogen Sheena McGowan, PhD, CEO and Co-Founder, Scudo Biosciences Ana Maria Moreno, CEO and Founder, Navega Therapeutics Josh Peters, CEO and Co-Founder, Prox Biosciences Carolina Pola, CEO, STAb Therapeutics J Ross, Ph.D., CEO and Co-Founder, Alleo Labs Tere Williams, CEO and Co-Founder, DUB Therapeutics